|
Market Cap (5-Jun) $109,489,168 (1,668th) |
Close (30-Jun) $0.095 |
Volume (30-Jun) 5,000 |
Shortsold (21-Oct) 1,626 (0.00%) (599th) |
|
52w High $0.63 |
52w Low $0.130 |
P/E - |
EPS -0.03 |
ILA released this announcement to the ASX on 7 February 2023, 14:16. The announcement is not marked as price sensitive, and is 3 page(s) in length and 178.94kb in size.
You can view all announcements from ILA and see how they appear on a price chart on the announcements page.
At the date of this announcement, ILA was 0.030% short sold according to ASIC data. It was ranked the 534th most shorted stock on the ASX. It remains ranked 599th as of the latest reported data (21 October 2025).
| Other Recent Announcements from ILA | |
|---|---|
| Island receives FDA go-ahead for ISLA-101 program | 16 May 2023, 9:09 |
| Replacement - Change in substantial holding | 27 April 2023, 17:29 |
| Change in substantial holding | 27 April 2023, 14:38 |
| Change in substantial holding | 7 February 2023, 14:16 |
| ILA receives additional FDA feedback on IND for ISLA 101 | 1 February 2023, 9:46 |
| Quarterly Activity Report & Appendix 4C | 30 January 2023, 9:03 |
| Island receives FDA feedback on Phase 2a clinical study | 20 January 2023, 9:51 |
You must be logged in to post a reply.
